The fact that JAK2-STAT3-mediated astrocyte reactivity contributes to three AD pathological outcomes contrasts with the beneficial effects of astrocytic STAT3 in spinal cord injury [4] or lack of effects after chemical lesions [58]. This evidence concerns the gene STAT3 and Alzheimer disease.